Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients

詳細情報 詳細情報について

• CRID

  1364233269827897344

• DOI

  10.1097/01.cji.0000211333.06762.47

• ISSN

  15249557

• Web Site

  https://journals.lww.com/10.1097/01.cji.0000211333.06762.47

• データソース種別

  • Crossref